Oligodendrocyte maturation is necessary for functional regeneration in the CNS; however, the mechanisms by which the systemic environment regulates oligodendrocyte maturation is unclear. We found that Transforming growth factor (TGF)-β1, which is present in higher levels in the systemic environment, promotes oligodendrocyte maturation. Oligodendrocyte maturation was enhanced by adult mouse serum treatment via TGF-β type I receptor. Decrease in circulating TGF-β1 level prevented remyelination in the spinal cord after toxin-induced demyelination. TGF-β1 administration promoted remyelination and restored neurological function in a multiple sclerosis animal model. Furthermore, TGF-β1 treatment stimulated human oligodendrocyte maturation. These data provide the therapeutic possibility of TGF-β for demyelinating diseases.
Pubmed ID: 31071011 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
A division of Applied Biosystems selling products for the isolation, detection, quantification, amplification, and characterization of RNA.
View all literature mentionsAmerican chemical, life science and biotechnology company owned by Merck KGaA. Merger of Sigma Chemical Company and Aldrich Chemical Company. Provides organic and inorganic chemicals, building blocks, reagents, advanced materials and stable isotopes for chemical synthesis, medicinal chemistry and materials science, antibiotics, buffers, carbohydrates, enzymes, forensic tools, hematology and histology, nucleotides, proteins, peptides, amino acids and their derivatives.
View all literature mentionsA commercial antibody supplier which supplies primary and secondary antibodies, biochemicals, proteins, peptides, lysates, immunoassays and other kits.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsThis monoclonal targets TGF-beta 1,-2,-3
View all literature mentionsThis unknown targets Rat IgG (H+L)
View all literature mentionsThis monoclonal targets TGFbeta RI (V-22)
View all literature mentionsThis polyclonal targets Mouse PDGF R alpha
View all literature mentionsThis monoclonal targets CD41
View all literature mentionsThis unknown targets Rabbit IgG
View all literature mentionsThis monoclonal targets Smad2/3 (D7G7) XP Rabbit mAb
View all literature mentionsThis monoclonal targets Phospho-Smad2 (Ser465/467)/Smad3 (Ser423/425)
View all literature mentionsThis unknown targets Goat IgG (H+L)
View all literature mentionsThis unknown targets Mouse IgG (H+L)
View all literature mentionsThis monoclonal targets APC
View all literature mentionsThis polyclonal targets Human Olig2
View all literature mentionsThis monoclonal targets Myelin Basic Protein
View all literature mentionsAllele Detail: Transgenic This is a legacy resource.
View all literature mentionsThis monoclonal targets TGF-beta 1,-2,-3
View all literature mentionsAllele Detail: Transgenic This is a legacy resource.
View all literature mentionsThis monoclonal targets Myelin Basic Protein
View all literature mentions